CDNF cDNA ORF clone, Homo sapiens(human)
Gene Symbol | CDNF |
Entrez Gene ID | 441549 |
Full Name | cerebral dopamine neurotrophic factor |
Synonyms | ARMETL1 |
General protein information |
|
Gene Type | protein-coding |
Organism | Homo sapiens(human) |
Genome | |
Disorder MIM: |
mRNA and Protein(s)
mRNA | Protein | Name |
---|---|---|
NM_001029954.2 | NP_001025125.2 | cerebral dopamine neurotrophic factor precursor |
NM_001029954.3 | NP_001025125.2 | cerebral dopamine neurotrophic factor precursor |
XM_011519488.2 | XP_011517790.1 | cerebral dopamine neurotrophic factor isoform X1 |

Homo sapiens (human) | CDNF | NP_001025125.2 |
Canis lupus familiaris (dog) | CDNF | XP_848954.2 |
Mus musculus (house mouse) | Cdnf | NP_808315.1 |
CDNF | XP_001088321.1 | |
Pan troglodytes (chimpanzee) | CDNF | XP_507666.2 |
Bos taurus (cattle) | CDNF | NP_001192698.1 |
Danio rerio (zebrafish) | cdnf | NP_001116753.1 |
Rattus norvegicus (Norway rat) | Cdnf | NP_001032632.1 |
Xenopus tropicalis (tropical clawed frog) | cdnf | XP_002935290.1 |

Related articles in PubMed
Association between cerebral dopamine neurotrophic factor (CDNF) 2 polymorphisms and schizophrenia susceptibility and symptoms in the Han Chinese population.
Yang Y, Yu H, Li W, Liu B, Zhang H, Ding S, Lu Y, Jiang T, Lv L
Behavioral and brain functions : BBF14(1)1(2018 Jan)
Cerebral Dopamine Neurotrophic Factor: A Potential Therapeutic Agent for Parkinson's Disease.
Tang T, Li Y, Jiao Q, Du X, Jiang H
Neuroscience bulletin33(5)568-575(2017 Oct)
Therapeutic efficacy of AAV8-mediated intrastriatal delivery of human cerebral dopamine neurotrophic factor in 6-OHDA-induced parkinsonian rat models with different disease progression.
Wang L, Wang Z, Zhu R, Bi J, Feng X, Liu W, Wu J, Zhang H, Wu H, Kong W, Yu B, Yu X
PloS one12(6)e0179476(2017)
Cerebral dopamine neurotrophic factor improves long-term memory in APP/PS1 transgenic mice modeling Alzheimer's disease as well as in wild-type mice.
Kemppainen S, Lindholm P, Galli E, Lahtinen HM, Koivisto H, H?m?l?inen E, Saarma M, Tanila H
Behavioural brain research2911-11(2015 Sep)
The Solution Structure and Dynamics of Full-length Human Cerebral Dopamine Neurotrophic Factor and Its Neuroprotective Role against ?-Synuclein Oligomers.
Latge C, Cabral KM, de Oliveira GA, Raymundo DP, Freitas JA, Johanson L, Rom?o LF, Palhano FL, Herrmann T, Almeida MS, Foguel D
The Journal of biological chemistry290(33)20527-40(2015 Aug)
GeneRIFs: Gene References Into Functions What's a GeneRIF?
The results showed that AAV8-CDNF administration significantly improved the motor function and increased the tyrosine hydroxylase (TH) levels in Parkinson's disease rats with mild lesions (2 weeks post lesion), but it had limited therapeutic effects in rats with severe lesions (5 weeks post lesion).
Title: Therapeutic efficacy of AAV8-mediated intrastriatal delivery of human cerebral dopamine neurotrophic factor in 6-OHDA-induced parkinsonian rat models with different disease progression.
Results suggest that CDNF treatment selectively enhances long-term memory consolidation
Title: Cerebral dopamine neurotrophic factor improves long-term memory in APP/PS1 transgenic mice modeling Alzheimer's disease as well as in wild-type mice.
showed that CDNF was able to protect dopaminergic neurons against injury caused by alpha-synuclein oligomers. This advises its use against physiological damages caused by alpha-synuclein oligomers
Title: The Solution Structure and Dynamics of Full-length Human Cerebral Dopamine Neurotrophic Factor and Its Neuroprotective Role against ?-Synuclein Oligomers.
Expression of CDNF in the substantia nigra has an anti-inflammatory effect on experimental Parkinson's disease.
Title: Transient transfection of human CDNF gene reduces the 6-hydroxydopamine-induced neuroinflammation in the rat substantia nigra.
Although no CDNF mutations are found in early-onset Parkinson's disease patient samples, a trend towards increased risk for Parkinson's in carriers of the C allele of rs7094179 single nucleotide polymorphism (SNP) is found.
Title: Analysis of mutations and the association between polymorphisms in the cerebral dopamine neurotrophic factor (CDNF) gene and Parkinson disease.
The following CDNF gene cDNA ORF clone sequences were retrieved from the NCBI Reference Sequence Database (RefSeq). These sequences represent the protein coding region of the CDNF cDNA ORF which is encoded by the open reading frame (ORF) sequence. ORF sequences can be delivered in our standard vector, pcDNA3.1+/C-(K)DYK or the vector of your choice as an expression/transfection-ready ORF clone. Not the clone you want? Click here to find your clone.
CloneID | OHu04393![]() |
|
Clone ID Related Accession (Same CDS sequence) | NM_001029954.2 , NM_001029954.3 | |
Accession Version | NM_001029954.2 | Documents for ORF clone product in default vector |
Sequence Information | ORF Nucleotide Sequence (Length: 564bp) Protein sequence SNP |
|
Vector | pcDNA3.1+/C-(K)DYK or customized vector | ![]() |
Clone information | Clone Map | ![]() |
Tag on pcDNA3.1+/C-(K)DYK | C terminal DYKDDDDK tags | |
ORF Insert Method | CloneEZ™ Seamless cloning technology | |
Insert Structure | linear | |
Update Date | 2017-09-17 | |
Organism | Homo sapiens(human) | |
Product | cerebral dopamine neurotrophic factor precursor | |
Comment | Comment: VALIDATED REFSEQ: This record has undergone validation or preliminary review. The reference sequence was derived from AV657190.1, CN311321.1, BG213461.1, BQ025443.1 and AK131035.1. On or before Dec 2, 2005 this sequence version replaced XM_497214.1, NM_001029954.1. ##Evidence-Data-START## Transcript exon combination :: SRR1660803.244857.1, SRR1660805.139062.1 [ECO:0000332] RNAseq introns :: single sample supports all introns SAMEA2467146 [ECO:0000348] ##Evidence-Data-END## COMPLETENESS: complete on the 3' end. |
1 | ATGTGGTGCG CGAGCCCAGT TGCTGTGGTG GCCTTTTGCG CCGGGCTTTT GGTCTCTCAC |
The stop codons will be deleted if pcDNA3.1+/C-(K)DYK vector is selected.
RefSeq | NP_001025125.2 |
CDS | 39..602 |
Translation |

Target ORF information:
Target ORF information:
|
![]() |

ORF Insert Sequence:
1 | ATGTGGTGCG CGAGCCCAGT TGCTGTGGTG GCCTTTTGCG CCGGGCTTTT GGTCTCTCAC |
The stop codons will be deleted if pcDNA3.1+/C-(K)DYK vector is selected.
CloneID | OHu04393![]() |
|
Clone ID Related Accession (Same CDS sequence) | NM_001029954.2 , NM_001029954.3 | |
Accession Version | NM_001029954.3 Latest version! | Documents for ORF clone product in default vector |
Sequence Information | ORF Nucleotide Sequence (Length: 564bp) Protein sequence SNP |
|
Vector | pcDNA3.1+/C-(K)DYK or customized vector | ![]() |
Clone information | Clone Map | ![]() |
Tag on pcDNA3.1+/C-(K)DYK | C terminal DYKDDDDK tags | |
ORF Insert Method | CloneEZ™ Seamless cloning technology | |
Insert Structure | linear | |
Update Date | 2019-04-30 | |
Organism | Homo sapiens(human) | |
Product | cerebral dopamine neurotrophic factor precursor | |
Comment | Comment: VALIDATED REFSEQ: This record has undergone validation or preliminary review. The reference sequence was derived from AC069544.9, AV657190.1, CN311321.1, BG213461.1, BQ025443.1 and AK131035.1. On Nov 23, 2018 this sequence version replaced NM_001029954.2. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Gene record to access additional publications. ##Evidence-Data-START## Transcript exon combination :: DC391788.1, SRR1660803.244857.1 [ECO:0000332] RNAseq introns :: single sample supports all introns SAMEA2467146 [ECO:0000348] ##Evidence-Data-END## ##RefSeq-Attributes-START## MANE Ensembl match :: ENST00000465530.2/ ENSP00000419395.1 RefSeq Select criteria :: based on conservation, expression ##RefSeq-Attributes-END## COMPLETENESS: full length. |
1 | ATGTGGTGCG CGAGCCCAGT TGCTGTGGTG GCCTTTTGCG CCGGGCTTTT GGTCTCTCAC |
The stop codons will be deleted if pcDNA3.1+/C-(K)DYK vector is selected.
RefSeq | NP_001025125.2 |
CDS | 92..655 |
Translation |

Target ORF information:
Target ORF information:
|
![]() |

ORF Insert Sequence:
1 | ATGTGGTGCG CGAGCCCAGT TGCTGTGGTG GCCTTTTGCG CCGGGCTTTT GGTCTCTCAC |
The stop codons will be deleted if pcDNA3.1+/C-(K)DYK vector is selected.
CloneID | OHu80351 | |
Clone ID Related Accession (Same CDS sequence) | XM_011519488.2 | |
Accession Version | XM_011519488.2 Latest version! | Documents for ORF clone product in default vector |
Sequence Information | ORF Nucleotide Sequence (Length: 591bp) Protein sequence SNP |
|
Vector | pcDNA3.1+/C-(K)DYK or customized vector | ![]() |
Clone information | Clone Map | ![]() |
Tag on pcDNA3.1+/C-(K)DYK | C terminal DYKDDDDK tags | |
ORF Insert Method | CloneEZ™ Seamless cloning technology | |
Insert Structure | linear | |
Update Date | 2019-12-05 | |
Organism | Homo sapiens(human) | |
Product | cerebral dopamine neurotrophic factor isoform X1 | |
Comment | Comment: MODEL REFSEQ: This record is predicted by automated computational analysis. This record is derived from a genomic sequence (NC_000010.11) annotated using gene prediction method: Gnomon, supported by mRNA and EST evidence. Also see: Documentation of NCBI's Annotation Process On Jun 6, 2016 this sequence version replaced XM_011519488.1. ##Genome-Annotation-Data-START## Annotation Provider :: NCBI Annotation Status :: Updated annotation Annotation Name :: Homo sapiens Updated Annotation Release 109.20191205 Annotation Version :: 109.20191205 Annotation Pipeline :: NCBI eukaryotic genome annotation pipeline Annotation Software Version :: 8.3 Annotation Method :: Best-placed RefSeq; propagated RefSeq model Features Annotated :: Gene; mRNA; CDS; ncRNA ##Genome-Annotation-Data-END## |
1 | ATGTGGTGCG CGAGCCCAGT TGCTGTGGTG GCCTTTTGCG CCGGGCTTTT GGTCTCTCAC |
The stop codons will be deleted if pcDNA3.1+/C-(K)DYK vector is selected.
RefSeq | XP_011517790.1 |
CDS | 128..718 |
Translation |

Target ORF information:
Target ORF information:
|
![]() |

ORF Insert Sequence:
1 | ATGTGGTGCG CGAGCCCAGT TGCTGTGGTG GCCTTTTGCG CCGGGCTTTT GGTCTCTCAC |
The stop codons will be deleted if pcDNA3.1+/C-(K)DYK vector is selected.
![]() |
Association between cerebral dopamine neurotrophic factor (CDNF) 2 polymorphisms and schizophrenia susceptibility and symptoms in the Han Chinese population. |
![]() |
Cerebral Dopamine Neurotrophic Factor: A Potential Therapeutic Agent for Parkinson's Disease. |
![]() |
Therapeutic efficacy of AAV8-mediated intrastriatal delivery of human cerebral dopamine neurotrophic factor in 6-OHDA-induced parkinsonian rat models with different disease progression. |
![]() |
Cerebral dopamine neurotrophic factor improves long-term memory in APP/PS1 transgenic mice modeling Alzheimer's disease as well as in wild-type mice. |
![]() |
The Solution Structure and Dynamics of Full-length Human Cerebral Dopamine Neurotrophic Factor and Its Neuroprotective Role against ?-Synuclein Oligomers. |